News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
340,607 Results
Type
Article (19798)
Company Profile (136)
Press Release (320673)
Section
Business (107744)
Career Advice (727)
Deals (25179)
Drug Delivery (75)
Drug Development (43043)
Employer Resources (65)
FDA (8074)
Job Trends (8197)
News (188528)
Policy (17498)
Tag
Academia (831)
Alliances (28301)
Alzheimer's disease (490)
Approvals (8085)
Artificial intelligence (120)
Bankruptcy (188)
Best Places to Work (6014)
Biotechnology (65)
Breast cancer (90)
Cancer (695)
Cardiovascular disease (64)
Career advice (630)
Cell therapy (118)
Clinical research (35705)
Collaboration (365)
Compensation (117)
COVID-19 (1077)
C-suite (91)
Data (675)
Diabetes (91)
Diagnostics (2294)
Drug pricing (67)
Earnings (40187)
Events (44423)
Executive appointments (330)
FDA (8477)
Funding (247)
Gene therapy (107)
GLP-1 (416)
Government (1768)
Healthcare (6391)
Infectious disease (1115)
Inflammatory bowel disease (66)
Interviews (105)
IPO (8027)
Job creations (2471)
Job search strategy (552)
Layoffs (251)
Legal (4417)
Lung cancer (105)
Lymphoma (62)
Manufacturing (155)
Medical device (3939)
Medtech (3941)
Mergers & acquisitions (17416)
Metabolic disorders (263)
Neuroscience (680)
NextGen: Class of 2025 (2604)
Non-profit (1239)
Northern California (743)
Obesity (159)
Opinion (143)
Patents (85)
People (33083)
Pharmaceutical (69)
Phase I (9590)
Phase II (15252)
Phase III (13333)
Pipeline (353)
Postmarket research (1571)
Preclinical (3937)
Radiopharmaceuticals (146)
Rare diseases (155)
Real estate (3210)
Regulatory (12148)
Research institute (882)
Resumes & cover letters (107)
Southern California (728)
Startups (2114)
United States (7595)
Vaccines (215)
Weight loss (118)
Date
Today (80)
Last 7 days (319)
Last 30 days (1351)
Last 365 days (17152)
2025 (1351)
2024 (17246)
2023 (19097)
2022 (26260)
2021 (27155)
2020 (25753)
2019 (21113)
2018 (16702)
2017 (17732)
2016 (16592)
2015 (19402)
2014 (15359)
2013 (13027)
2012 (13921)
2011 (14539)
2010 (13303)
Location
Africa (410)
Arizona (69)
Asia (24237)
Australia (3283)
California (1823)
Canada (921)
China (209)
Colorado (78)
Connecticut (104)
Europe (49502)
Florida (311)
Illinois (193)
Indiana (139)
Japan (76)
Maryland (257)
Massachusetts (1511)
Minnesota (100)
New Jersey (717)
New York (515)
North Carolina (460)
Northern California (743)
Ohio (62)
Pennsylvania (485)
South America (659)
Southern California (728)
Texas (234)
Virginia (61)
Washington State (146)
340,607 Results for "arcutis pharmaceuticals acquired by valeant pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arcutis to Present at the Guggenheim SMID Cap Biotech Conference
January 27, 2025
·
2 min read
Press Releases
Arcutis Announces Promotions on Executive Management Team
December 3, 2024
·
5 min read
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
Press Releases
Arcutis Announces ZORYVE® U.S. Co-promote Agreement with Kowa Pharmaceuticals America, Inc.
July 29, 2024
·
7 min read
Deals
Cycle Pharmaceuticals Announces All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share
Cycle Pharmaceuticals Ltd today confirmed that it made a proposal to the Board of Directors of Vanda Pharmaceuticals, Inc. (“Vanda”) (NASDAQ: VNDA) on May 24, 2024 to acquire 100% of Vanda’s issued and outstanding shares for a cash consideration of $8.00 per Vanda share, representing a total cash consideration of $466 million.
June 6, 2024
·
5 min read
Deals
Future Pak Issues Enhanced and Final Proposal to Acquire Vanda Pharmaceuticals Inc.
Future Pak, LLC and its affiliates announced that it has submitted a final attempt to engage with Vanda Pharmaceuticals Inc. in a good faith effort to acquire all outstanding shares of Vanda.
June 13, 2024
·
4 min read
Biotech Bay
Arcutis to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Arcutis Biotherapeutics, Inc. today announced that Arcutis management will participate in the Goldman Sachs 45th Annual Global Healthcare Conference, taking place June 10-13, 2024.
June 3, 2024
·
2 min read
Deals
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd.
April 29, 2024
·
10 min read
Business
Arcutis and Sato Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Japan
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) and Sato Pharmaceutical Co., Ltd., a leading pharmaceutical company, today announced that the companies have entered into a strategic collaboration and licensing agreement for the development, manufacture, and commercialization of topical roflumilast in Japan.
February 28, 2024
·
6 min read
Press Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 6, 2025
January 7, 2025
·
3 min read
1 of 34,061
Next
